Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

306.50p
   
  • Change Today:
    -8.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.01m
  • Volume: 230,543
  • Market Cap: £306.54m
  • RiskGrade: 125

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 129.23 (39.05) (40.79)p n/a n/a n/a n/a 0.0%
31-Dec-25 164.63 (22.27) (25.32)p n/a n/a n/a n/a 0.0%
31-Dec-26 207.43 6.18 (3.95)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 54.02 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

OXB Market Data

Currency UK Pounds
Share Price 306.50p
Change Today -8.50p
% Change -2.70 %
52 Week High 470.00
52 Week Low 166.80
Volume 230,543
Shares Issued 100.01m
Market Cap £306.54m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.71% below the market average26.71% below the market average26.71% below the market average26.71% below the market average26.71% below the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Price Trend
8.48% below the market average8.48% below the market average8.48% below the market average8.48% below the market average8.48% below the market average
32.08% above the sector average32.08% above the sector average32.08% above the sector average32.08% above the sector average32.08% above the sector average
Income Not Available
Growth
52.57% below the market average52.57% below the market average52.57% below the market average52.57% below the market average52.57% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
16:35 40,557 @ 306.50p
16:35 141 @ 306.50p
16:35 459 @ 306.50p
16:35 150 @ 306.50p
16:35 449 @ 306.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page